hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distr...

FDA Recall #D-0653-2022 — Class II — February 24, 2022

Recall #D-0653-2022 Date: February 24, 2022 Classification: Class II Status: Terminated

Product Description

hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.

Recalling Firm

The Harvard Drug Group — Livonia, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

5,953 cartons

Distribution

Nationwide within USA

Code Information

Lot #: T03755, T03756, Exp. Date 03/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated